United States

Biovest files for Ch. 11 bankruptcy protection

Friday, March 8, 2013 03:04 PM

Tampa, Fla.-based Biovest International has filed a petition for protection under Chapter 11 of the U.S. Bankruptcy Code and a Plan of Reorganization seeking to implement a restructuring of its balance sheet that would eliminate approximately $44 million in senior secured debt held by Laurus/Valens Funds and Corp Real, while also providing up to approximately $5.6 million in new operating funding.

More... »

Janssen launches global cardiovascular research program, five new studies

Friday, March 8, 2013 10:47 AM

Janssen Research & Development has launched EXPLORER, a comprehensive, global research program for XARELTO (rivaroxaban), an oral anticoagulant. The program includes studies that will evaluate XARELTO for investigational use in patients with chronic heart failure and in those with coronary artery disease or peripheral artery disease.

More... »

Leukemia & Lymphoma Society expands chief policy, advocacy officer role

Friday, March 8, 2013 10:34 AM

The Leukemia & Lymphoma Society (LLS) has expanded the role of chief policy and advocacy officer Mark Velleca, M.D., Ph.D. Velleca, who has headed LLS' Office of Public Policy in Washington, D.C., since early 2012, will now oversee the newly integrated patient advocacy, policy and programs department.

More... »

CFS Clinical launches upgraded business intelligence platform for clinical trials

Friday, March 8, 2013 10:30 AM

Audubon, Pa.-based CFS Clinical, a specialty provider of business and financial management activities for clinical trials, has launched its upgraded technology platform and new tax consulting services.

More... »

Sitrof promotes Kivlehan to director of mobility and collaboration

Thursday, March 7, 2013 01:43 PM

Princeton, N.J.-based Sitrof Technologies, a developer of content management, process harmonization and compliance solutions for the life sciences industry, has promoted Thomas Kivlehan to director, mobility and collaboration.

More... »

Personal Genome Diagnostics hires chief commercial officer

Thursday, March 7, 2013 01:41 PM

Baltimore-based Personal Genome Diagnostics (PGDx), a pioneer in conducting patient-specific analyses aimed at identifying genomic alterations in tumors, has recruited veteran industry executive Antony Newton as it prepares for accelerated growth.

More... »

Delta Point hires former AstraZeneca exec Michael Hickey

Thursday, March 7, 2013 01:40 PM

Michael Hickey, former vice president of U.S. sales at AstraZeneca and former president of AstraZeneca, Netherlands, has joined Delta Point of Malvern, Pa., as senior vice president of global leadership development.

More... »

Merck names Roger Perlmutter president of Merck Research Laboratories

Thursday, March 7, 2013 01:37 PM

Merck has appointed Roger M. Perlmutter, M.D., Ph.D., executive vice president and president of Merck Research Laboratories (MRL), effective April 15. Dr. Perlmutter will succeed Peter S. Kim, Ph.D., who has served in the role since 2003. To ensure a seamless transition, Dr. Perlmutter and Dr. Kim will work closely together for an initial period, after which Dr. Kim will remain with the company as an advisor until his retirement in August.

More... »

Accelovance acquires CRO Radiant Development

Thursday, March 7, 2013 01:32 PM

Rockville, Md.-based CRO  Accelovance has announced the acquisition of Radiant Development, the CRO division of Radiant Research. Terms of the transaction were not disclosed. 

More... »

Marken appoints two independent directors to board

Tuesday, March 5, 2013 04:10 PM

Marken, based in Research Triangle Park, N.C., has appointed two independent directors to its board, as a result of Marken's recent restructuring completed Dec. 21, 2012.  They are Timothy C. Tyson and Michael O'Donnell.

More... »